Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $262.02 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $92.50 | 5 | $0 (2024) |
| Lilly USA, LLC | $57.42 | 4 | $0 (2024) |
| Novo Nordisk Inc | $52.44 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $22.09 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.05 | 1 | $0 (2023) |
| Amgen Inc. | $17.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126.57 | 7 | Novo Nordisk Inc ($36.81) |
| 2023 | $135.45 | 8 | ABBVIE INC. ($56.56) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes | ||||||
| 05/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Cardio-renal | ||||||
| 02/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 11/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 07/20/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 202 | 253 | $28,252 | $10,059 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 110 | $16,946 | $5,125 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $2,338 | $1,434 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 15 | $3,917 | $971.88 | 24.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $825.00 | $808.50 | 98.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 14 | $742.00 | $485.79 | 65.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $840.00 | $369.49 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $364.00 | $356.72 | 98.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $506.00 | $178.20 | 35.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 17 | $425.00 | $142.80 | 33.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 15 | $870.00 | $142.80 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 20 | $480.00 | $44.00 | 9.2% |
About Heather Murray, NP
Heather Murray, NP is a Family healthcare provider based in Buena Vista, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2023. The National Provider Identifier (NPI) number assigned to this provider is 1124713532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Murray, NP has received a total of $262.02 in payments from pharmaceutical and medical device companies, with $126.57 received in 2024. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($262.02).
As a Medicare-enrolled provider, Murray has provided services to 202 Medicare beneficiaries, totaling 253 services with total Medicare billing of $10,059. Data is available for 1 year (2023–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Buena Vista, GA
- Active Since 04/11/2023
- Last Updated 04/10/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124713532
Products in Payments
- VRAYLAR (Drug) $92.50
- Ozempic (Drug) $36.81
- TRULICITY (Drug) $30.45
- MOUNJARO (Drug) $26.97
- Kerendia (Drug) $22.09
- Otezla (Drug) $17.52
- Rybelsus (Drug) $15.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Buena Vista
Ms. Janet Ommen, Msn, Fnp, MSN, FNP
Family — Payments: $106.64
Laura Mays, Fnp-C, FNP-C
Family — Payments: $16.74
Mrs. Beth Cullen, Fnp-C, FNP-C
Family
Linda Typer, Cnp, CNP
Family
Mrs. Judy Catrett, A.p.r.n-C, A.P.R.N-C
Family
Rachel Flavin, Fnp, FNP
Family